Recommended antibiotic therapy in episodes of urinary tract infection;Tratamiento antibiótico recomendado en episodios de infección urinaria

Anales de Pediatria

Volumn 67, Issue 5, 2007, Pages 485-497

  Ochoa Sangrador, C ^a   Brezmes Raposo, M ^b   Perez Mendez C ^c   Solis Sanchez G ^c   Molina Cabanero J C ^d   Lara Herguedas, J ^d   Conde Redondo, F ^e   Bachiller Luque, R ^e   Eiros Bouza, J Ma ^e   Matias Del Pozo V ^e   Nogueira Gonzalez B ^e   Uruena Leal Ma C ^f   Andres De Llano J M ^f   Rostami, P ^f   Saenz Martin J F ^f   Formigo Rodriguez E ^g   Cueto Baelo, M ^g   Gonzalez Novoa Ma G ^g   Silva Higuero, N ^h   Gonzalez Garcia H ^h   Gonzalez De Dios J ⁱ   Uran Moreno Ma M ^j   Gea Ros, J M ^j   Barajas Sanchez Ma V ^a   Brezmes Valdivieso, Ma F ^a   Fernandez Testa Ma A ^a   more..

^a HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL DE CABUEÑES   (Spain)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^f Gerencia Regional de Salud de Castilla y León   (Spain)

^g HOSPITAL XERAL CÍES   (Spain)

^h Hospital de Medina del Campo   (Spain)

ⁱ HOSPITAL DE TORREVIEJA   (Spain)

^j HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

more..

Author keywords

Antibiotics; Child; Consensus development conference; Evidence based medicine; Treatment; Urinary tract infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CEPHALOSPORIN; COTRIFAMOLE; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; PIVAMPICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; CYSTITIS; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FEMALE; FEVER; HUMAN; MALE; NEPHROTOXICITY; OTOTOXICITY; REVIEW; SPAIN; URINARY TRACT INFECTION;

EID: 35948979628     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13111602     Document Type: Review

References (110)

1. Ochoa Sangrador C, Eiros Bouza JM, Méndez CP, Inglada Galiana L, y Grupo de Estudio de los Tratamientos Antibioticos. Etiología de las infecciones del tracto urinario y sensibilidad de los uropatógenos a los antimicrobianos. Rev Esp Quimioter. 2005;18:124-35.
2. Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, et al. Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigation of urinary tract infection in children: A systematic review and economic model. Health Technol Assess. 2006;10:1-172.
3. Biggi A, Dardanelli L, Pomero G, Cussino P, Noello C, Sernia O, et al. Acute renal cortical scintigraphy in children with a first urinary tract infection. Pediatr Nephrol. 2001;16:733-8.
4. mTc DMSA scanning in the localization of childhood urinary tract infections. Int Urol Nephrol. 1993;25:11-7.
5. Castello Girona F, Vilaplana Canto E, Yeste Fernández D, Roca Bielsa I, Enríquez Civico G. Gammagrafía con 99mtecnecio- ácido dimercaptosuccinico en el estudio de la primera infección urinaria del lactante. An Esp Pediatr. 1995;42:118-22.
6. mTc DMSA scintigraphy in the diagnosis and follow-up of acute pyelonephritis and cystitis in children. Eur Urol. 1998;34:486-91.
7. Fretzayas A, Moustaki M, Gourgiotis D, Bossios A, Koukoutsakis P, Stavrinadis C. Polymorphonuclear elastase as a diagnostic marker of acute pyelonephritis in children. Pediatrics. 2000;105:E28.
8. Gervaix A, Galetto-Lacour A, Gueron T, Vadas L, Zamora S, Suter S, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J. 2001;20:507-11.
9. Landau D, Turner ME, Brennan J, Majd M. The value of urinalysis in differentiating acute pyelonephritis from lower urinary tract infection in febrile infants. Pediatr Infect Dis J. 1994;13:777-81.
10. Robles García B, Rodríguez Fernández LM, Suárez Rodríguez MA, Marugán de Miguelsanz JM, Fernández Castaño M, De Fuentes Acebes MC. Comparación de la utilidad de la fiebre y de algunos parámetros analíticos para el diagnóstico de pielonefritis aguda en niños. Rev Esp Pediatr. 2005;61:358-63.
11. Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatr Nephrol. 2002;17:409-12.
12. Bigot S, Leblond P, Foucher C, Hue V, D'Herbomez M, Foulard M. Apport du dosage de la procalcitonine pour le diagnostic de pyelonephrite aiguü de l'enfant. Arch Pediatr. 2005;12:1075-80.
13. Canning DA. Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infections to age 2. J Urol. 2005;174:2011.
14. Chiou YY, Chiu NT, Chen MJ, Cheng HL. Role of beta 2-microglobulinuria and microalbuminuria in pediatric febrile urinary tract infection. Acta Paediatr Taiwan. 2001;42:84-9.
15. Krzemien G, Roszkowska-Blaim M, Kostro I, Szmigielska A, Karpinska M, Sieniawska M, et al. Urinary levels of interleukin-6 and interleukin-8 in children with urinary tract infections to age 2. Med Sci Monit. 2004;10:CR593-7.
16. Downs SM. Technical report: Urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement. Pediatrics. 1999;103:e54.
17. Bloomfield P, Hodson EM, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev. 2005:CD003772.
18. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP. Extended-interval aminoglycoside administration for children: A meta-analysis. Pediatrics. 2004;114:e111-8.
19. Carapetis JR, Jaquiery AL, Buttery JP, Starr M, Cranswick NE, Kohn S, et al. Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infect Dis J. 2001;20:240-6.
20. Chong CY, Tan AS, Ng W, Tan-Kendrick A, Balakrishnan A, Chao SM. Treatment of urinary tract infection with gentamicin once or three times daily. Acta Paediatr. 2003;92:291-6.
21. Tapaneya-Olarn C, Tapaneya-Olarn W, Pitayamornwong V, Petchthong T, Tangnararatchakit K. Single daily dose of gentamicin in the treatment of pediatric urinary tract infection. J Med Assoc Thai. 1999;82 Suppl 1:S93-7.
22. Vigano A, Principi N, Brivio L, Tommasi P, Stasi P, Villa AD. Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram twice daily for treatment of gram-negative pyelonephritis in children. Antimicrob Agents Chemother. 1992;36:1499-503.
23. Francois P, Bensman A, Begue P, Artaz MA, Coudeville L, Lebrun T, et al. Évaluation de l'efficacité et du coût de deux strategies therapeutiques dans les pyelonephrites de l'enfant: Cefixime per os versus ceftriaxone parenterale en relais d'une bitherapie intraveineuse. Med Mal Infect. 1997;27:667-73.
24. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics. 1999;104:79-86.
25. Keren R, Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics. 2002;109:E70.
26. Michael M, Hodson EM, Craig JC, Martín S, Moyer VA. Short compared with standard duration of antibiotic treatment for urinary tract infection: A systematic review of randomised controlled trials. Arch Dis Child. 2002;87:118-23.
27. Michael M, Hodson EM, Craig JC, Martín S, Moyer VA. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev. 2003:CD003966.
28. Tran D, Muchant DG, Aronoff SC. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: A meta-analysis of 1279 patients. J Pediatr. 2001;139:93-9.
29. Montini G, Murer L, Gobber D, Commacchio S, Toffolo A, Dall'Amico R, et al. Oral vs initial intravenous antibiotic treatment of urinary tract infections in children: A multicentre study. Nephrol Dial Transplant. 2003;18 Suppl 4:816a.
30. Gok F, Duzova A, Baskin E, Ozen S, Besbas N, Bakkaloglu A. Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children. J Chemother. 2001;13:277-80.
31. Khan AJ, Kumar K, Evans HE. Single-dose gentamicin therapy of recurrent urinary tract infection in patients with normal urinary tracts. J Pediatr. 1987;110:131-5.
32. Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics. 2004;114:e469-76.
33. Calvo Rey C, García Díaz B, García García M, García Lacalle C, Nebreda Pérez V, Cilleruelo Pascual M, et al. Gentamicina en dosis única diaria frente a tres dosis diarias en lactantes con pielonefritis aguda. An Pediatr (Barc). 2003;58:228-31.
34. Dagan R, Einhorn M, Lang R, Pomeranz A, Wolach B, Miron D, et al. Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children. Pediatr Infect Dis J. 1992;11:198-203.
35. Banfi AGG, Hill-Juarez JM, Kaufman A, E M. Multinational comparative trial of ceftibuten and trimethoprim-sulfamethoxazole in the treatment of children with complicated or recurrent urinary tract infections. Members of the ceftibuten urinary tract infection international study group. Pediatr Infect Dis J. 1993;12 Suppl. 6:S 84-S 91.
36. Chibante A, Peixoto E, Lejeune R, Winter K, Kissling M. Clinical efficacy and safety of cefetamet pivoxil in toddlers. Int J Antimicrob Agents. 1994;4:203-10.
37. Francois P, Croize J, Bost C, Wollschlager K. Étude comparant le céfixime à l'association amoxicilline-acide clavulanique dans le traitement par voie orale des infections urinaires de l'enfant. Arch Pediatr. 1995;2:136-42.
38. Kenda R, Kaplar VM, Jeler D, Kunstelj T, Truden E, Smole A. The treatment of bacterial infection of the urinary tract in infants and small children using Amoksiklav. Paediatria Croatica. 1995;39:155-8.
39. Roca Martínez J, Durán Bellido M, Suris Granell JC, Iglesias Salvador D, Hidalgo Ibáñez MJ, Juncosa Morros T, et al. Amoxicilina mas ácido clavulánico en el tratamiento de las infecciones urinarias en pediatría. An Esp Pediatr. 1990;32:53-7.
40. Conde Redondo F, Gómez García S, Álvarez García J, Valvuena Crespo C. La asociación amoxicilina más ácido clavulánico en el tratamiento de la infección urinaria en pediatría. Pediatrika. 1989;9:314-8.
41. Begue P, Astruc J, Francois P, Floret D. Évaluation de la ceftriaxone et du céfotaxime dans l'infection bactérienne sévère en pédiatrie: étude multicentrique. Med Mal Infect. 1998;28:300-6.
42. Canduela Martínez V, Mongil Ruiz I, Cagigas Daza P, Docio Nieto S. Tratamiento de la infección urinaria en lactantes con ceftriaxona. Rev Esp Pediatr. 1995;51:341-3.
43. Schaad UB, Eskola J, Kafetzis D, Fishbach M, Ashkenazi S, Syriopoulou V, et al. Cefepine vs. ceftazidime treatment of pyelonephritis: A European, randomized, controlled study of 300 pediatric cases. European Society for Paediatric Infectious Diseases (ESPID) Pyelonephritis Study Group. Pediatr Infect Dis J. 1998;17:639-44.
44. Jodal U. The role of fosfomycin trometamol in the management of urinary tract infections in pediatrics. Infection. 1992;20 Suppl 4:S317-20.
45. Principi N, Corda R, Bassetti D, Varese LA, Peratoner L. Fosfomycin trometamol versus netilmicin in children's lower urinary tract infections. Chemotherapy. 1990;36 Suppl 1:41-5.
46. Careddu P, Borzani M, Scotti L, Varotto F, Garlaschi L, Fontana P. Treatment of lower urinary tract infections in children: Single dose fosfomycin trometamol versus pipemidic acid. Chemioterapia. 1987;6:290-4.
47. Varese LA. Trometamol salt of fosfomycin versus netilmicin: Randomized multicenter study in children's lower urinary tract infections. Eur Urol. 1987;13 Suppl 1:119-21.
48. Careddu P, Borzani M, Varotto F, Garlaschi L, Fontana P. Trometamol salt of fosfomycin (Monuril). Preliminary pharmacokinetic and clinical experience in the treatment of urinary tract infections in children. Eur Urol. 1987;13 Suppl 1:114-8.
49. Bose W, Karama A, Linzenmeier G, Olbing H, Wellmann P. Controlled trial of co-trimoxazole in children with urinary-tract infection. Bacteriological efficacy and haematological toxicity. Lancet. 1974;2:614-6.
50. Feldman W, Johnson DM, Newberry P, Weldon A, Naidoo S. Comparison of trimethoprim-sulfamethoxazole with sulfamethoxazole in urinary tract infections of children. Can Med Assoc J. 1975;112:19-21.
51. Weber HP, Aberfeld U, Hildenbrand G, Knopfle G. Behandlung von ersten Harnwegsinfekten im Kindesalter mit Cotrifamol und Cotrimoxazol. Dtsch Med Wochenschr. 1982;107:837-41.
52. Helin I, Jodal U. Treatment of childhood pyelonephritis with two daily doses of pivampicillin. Lakartidningen. 1978;75:1825-6.
53. Callis L, Lara E, Vila A. Resultados del tratamiento con aztreonama de infecciones urinarias en pediatría. Rev Esp Microbiol Clin. 1989;4:93-6.
54. Kafetzis DA, Maltezou HC, Mavrikou M, Siafas C, Paraskakis I, Delis D, et al. Isepamicin versus amikacin for the treatment of acute pyelonephritis in children. Int J Antimicrob Agents. 2000;14:51-5.
55. Rocca Rossetti S. Single-shot vs conventional therapy with amikacin for treatment of uncomplicated urinary tract infections: A multicenter study. Chemioterapia. 1986;5:394-9.
56. Moe OJ, Meberg A, Eng J. Ampicillin and pivampicillin in the treatment of urinary tract infection in children. Scand J Infect Dis. 1977;9:31-6.
57. Piekkala P, Huovinen P, I V. Comparative study of cefuroxime vs. amoxycillin in the parenteral treatment of children with upper urinary tract infection. Curr Ther Res Clin Exp. 1985;37:1152-9.
58. Russo RM, Gururaj VJ, Laude TA, Rajkumar SV, Allen JE. The comparative efficacy of cephalexin and sulfisoxazole in acute urinary tract infection in children. Clin Pediatr (Phila). 1977;16:83-4, 9-91.
59. Koyle MA, Barqawi A, Wild J, Passamaneck M, Furness PD, 3rd. Pediatric urinary tract infections: The role of fluoroquinolones. Pediatr Infect Dis J. 2003;22:1133-7.
60. Pylkkanen J, Vilska J, Koskimies O. The length of antimicrobial therapy in upper vs. lower urinary tract infection of childhood. Acta Paediatr Scand. 1981;70:885-8.
61. Copenhagen Study Group of Urinary Tract Infections in Children. Short-term treatment of acute urinary tract infection in girls. Scand J Infect Dis. 1991;23:213-20.
62. Frimodt-Møller N. Correlation between pharmacokinetic/ pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents. 2002;19:546-53.
63. Stahl GE, Topf P, Fleisher GR, Norman ME, Rosenblum HW, Gruskin AB. Single-dose treatment of uncomplicated urinary tract infections in children. Ann Emerg Med. 1984;13:705-8.
64. Avner ED, Ingelfinger JR, Herrin JT, Link DA, Marcus E, Tolkoff-Rubin NE, et al. Single-dose amoxicillin therapy of uncomplicated pediatric urinary tract infections. J Pediatr. 1983;102:623-7.
65. Shapiro ED, Wald ER. Single-dose amoxicillin treatment of urinary tract infections. J Pediatr. 1981;99:989-92.
66. Bailey RR, Abbott GD. Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole. Can Med Assoc J. 1978;118:551-2.
67. Madrigal G, Odio CM, Mohs E, Guevara J, McCracken GH, Jr. Single dose antibiotic therapy is not as effective as conventional regimens for management of acute urinary tract infections in children. Pediatr Infect Dis J. 1988;7:316-9.
68. Nolan T, Lubitz L, Oberklaid F. Single dose trimethoprim for urinary tract infection. Arch Dis Child. 1989;64:581-6.
69. Pitt WR, Dyer SA, McNee JL, Burke JR. Single dose trimethoprim- sulphamethoxazole treatment of symptomatic urinary infection. Arch Dis Child. 1982;57:229-31.
70. Wientzen RL, McCracken GH, Jr, Petruska ML, Swinson SG, Kaijser B, Hanson LA. Localization and therapy of urinary tract infections of childhood. Pediatrics. 1979;63:467-74.
71. Helin I. Short-term treatment of lower urinary tract infections in children with trimethoprim/sulphadiazine. Infection. 1981;9:249-51.
72. Al Roomi LG, Sutton AM, Cockburn F, McAllister TA. Amoxycillin and clavulanic acid in the treatment of urinary infection. Arch Dis Child. 1984;59:256-9.
73. Cohen M. The first urinary tract infection in male children. Am J Dis Child. 1976;130:810-13.
74. Ellerstein NS, Sullivan TD, Baliah T, Neter E. Trimethoprim/ sulfamethoxazole and ampicillin in the treatment of acute urinary tract infections in children: A double-blind study. Pediatrics. 1977;60:245-7.
75. Fennell RS, Luengnaruemitchai M, Iravani A, Garin EH, Walker RD, Richard GA. Urinary tract infections in children: Effect of short course antibiotic therapy on recurrence rate in children with previous infections. Clin Pediatr (Phila). 1980;19:121-4.
76. Khan AJ, Ubriani RS, Bombach E, Agbayani MM, Ratner H, Evans HE. Initial urinary tract infection caused by Proteus mirabilis in infancy and childhood. J Pediatr. 1978;93:791-3.
77. Sullivan TD, Ellerstein NS, Neter E. The effects of ampicillin and trimethoprim/sulfamethoxazole on the periurethral flora of children with urinary tract infection. Infection. 1980; 8 Suppl 3:S 339-41.
78. Aarbakke J, Opshaug O, Digranes A, Hoylandskjaer A, Fluge G, Fellner H. Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections. Eur J Clin Pharmacol. 1983;24:267-71.
79. Hashemi G. Recurrent urinary tract infection. Indian J Pediatr. 1985;52:401-3.
80. Howard JB, Howard JE, Sr. Trimethoprim-sulfamethoxazole vs sulfamethoxazole for acute urinary tract infections in children. Am J Dis Child. 1978;132:1085-7.
81. Rajkumar S, Saxena Y, Rajagopal V, Sierra MF. Trimethoprim in pediatric urinary tract infection. Child Nephrol Urol. 1988;9:77-81.
82. Levtchenko E, Lahy C, Levy J, Ham H, Piepsz A. Treatment of children with acute pyelonephritis: A prospective randomized study. Pediatr Nephrol. 2001;16:878-84.
83. Vilaichone A, Watana D, Chaiwatanarat T. Oral ceftibuten switch therapy for acute pyelonephritis in children. J Med Assoc Thai. 2001;84 Suppl 1:S61-7.
84. Benador D, Neuhaus TJ, Papazyan JP, Willi UV, Engel-Bicik I, Nadal D, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: Effect on renal scarring. Arch Dis Child. 2001;84:241-6.
85. Baker PC, Nelson DS, Schunk JE. The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med. 2001;155:135-9.
86. Fischbach M, Simeoni U, Mengus L, Jehl F, Monteil H, Geisert J, et al. Urinary tract infections with tissue penetration in children: Cefotaxime compared with amoxycillin/clavulanate. J Antimicrob Chemother. 1989;24 Suppl B:177-83.
87. Toporovski J, Steffens L, Noack M, Kranz A, Burdeska A, Kissling M. Effectiveness of cefetamet pivoxil in the treatment of pyelonephritis in children. J Int Med Res. 1992;20:87-93.
88. Grimwood K, Abbott GD, Fergusson DM. Single dose gentamicin treatment of urinary infections in children. N Z Med J. 1988;101:539-41.
89. Repetto HA, MacLoughlin GJ. Single-dose cefotaxime in the treatment of urinary tract infections in children: A randomized clinical trial. J Antimicrob Chemother. 1984;14 Suppl B:307-10.
90. Fine JS, Jacobson MS. Single-dose versus conventional therapy of urinary tract infections in female adolescents. Pediatrics. 1985;75:916-20.
91. Gaudreault P, Beland M, Girodias JB, Thivierge RL. Single daily doses of trimethoprim/sulphadiazine for three or 10 days in urinary tract infections. Acta Paediatr. 1992;81:695-7.
92. Helin I. Three-day therapy with cephalexin for lower urinary tract infections in children. Scand J Infect Dis. 1984;16: 305-7.
93. Johnson CE, Maslow JN, Fattlar DC, Adams KS, Arbeit RD. The role of bacterial adhesins in the outcome of childhood urinary tract infections. Am J Dis Child. 1993;147:1090-3.
94. Jojart G. Comparison of 3-day versus 14-day treatment of lower urinary tract infection in children. Int Urol Nephrol. 1991;23:129-34.
95. Khan AJ, Kumar K, Evans HE. Three-day antimicrobial therapy of urinary tract infection. J Pediatr. 1981;99:992-4.
96. Kornberg AE, Sherin K, Veiga P, Mydlow PK, Collins JJ, Feld LG. Two-day therapy with cefuroxime axetil is effective for urinary tract infections in children. Am J Nephrol. 1994;14:169-72.
97. Lidefelt KJ, Bollgren I, Wiman A. Single dose treatment of cystitis in children. Acta Paediatr Scand. 1991;80:648-53.
98. Lohr JA, Hayden GF, Kesler RW, Gleason CH, Wood JB, Ford RF, et al. Three-day therapy of lower urinary tract infections with nitrofurantoin macrocrystals: A randomized clinical trial. J Pediatr. 1981;99:980-3.
99. McCracken GH, Jr, Ginsburg CM, Namasonthi V, Petruska M. Evaluation of short-term antibiotic therapy in children with uncomplicated urinary tract infections. Pediatrics. 1981;67:796-801.
100. Wallen L, Zeller WP, Goessler M, Connor E, Yogev R. Single-dose amikacin treatment of first childhood E. coli lower urinary tract infections. J Pediatr. 1983;103:316-9.
101. Portilla MG, Rolfe U. Single-dose vs ten-day antibiotic therapy for uncomplicated urinary tract infection in children. Am J Dis Child. 1987;141:392.
102. Zaki M, Helin I. Nalidixic acid and trimethoprim/sulphamethoxazole as alternatives for short-term treatment of urinary infections. Ann Trop Paediatr. 1986;6:205-7.
103. Tambic T, Oberiter V, Delmis J, Tambic A. Diagnostic value of a P-fimbriation test in determining duration of therapy in children with urinary tract infections. Clin Ther. 1992;14:667-71.
104. Guidelines for the management of acute urinary tract infection in childhood. Report of a Working Group of the Research Unit, Royal College of Physicians. J R Coll Physicians Lond. 1991;25:36-42.
105. Malo Rodríguez C, Echeverry Raad J, Iragorri S, Gastelbondo R. Infección urinaria (IU) en niños menores de dos años. Sociedad Colombiana de Urología. 1999. Accesible en línea [fecha de consulta: 29-XI-2006]. Disponible en: http://www.encolombia.com/medicina/ pediatria/pedi36201-infeccioniu.htm.
106. Practice parameter: The diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics. 1999;103:843-52.
107. Bagga A, Babu K, Kanitkar M, Srivastava RN. Consensus statement on management of urinary tract infections. Indian Pediatr. 2001;38:1106-15.
108. Loris C, Carpena R, Escribano J, Málaga S. Infección urinaria. Protocolos de la Asociación Española de Pediatría. Accesible en línea [fecha de consulta: 29-XI-2006]. Disponible en: http://www.aeped.es/protocolos/nefro/index.htm.
109. Carballo Ruano E, Luaces Cubells C, Pou Fernández J, Camacho Díaz JA, Jiménez Llort A. Guía de práctica clínica de la infección urinaria en Pediatría. Sociedad Española de Urgencias Pediátricas. Barcelona 2004.
110. Urinary tract infection - children - PRODIGY Knowledge Guidance. Accesible en línea [fecha de consulta: 29-XI-2006] Disponible en: http://www.prodigy.nhs.uk/urinary_tract_infection_children.